GHK Cu Peptide Injection: Purity, Specifications, Manufacturing & Sourcing Guide for Labs

Core Molecular Specs & Technical Index

The GHK Cu peptide injection, also known as copper tripeptide-1, is a high-purity raw material designed for laboratory research and cosmetic formulation development. This peptide complex consists of the tripeptide glycyl-histidyl-lysine (GHK) bound to a copper ion (Cu²⁺), which stabilizes the molecule and enhances its functional properties in experimental settings. For B2B buyers—including cosmetic R&D labs, peptide manufacturers, and bulk raw material distributors—the core value lies in its defined molecular structure, verified purity levels, and consistent batch-to-batch performance. This guide provides the technical specifications, manufacturing standards, and sourcing criteria necessary for informed procurement decisions.

Core Molecular Specs & Technical Index

The GHK Cu peptide injection is defined by precise chemical and physical parameters that determine its suitability for advanced research and formulation. Below are the essential technical indices that every lab buyer must verify before procurement.

Basic Properties

• Molecular Formula: C₁₄H₂₄N₆O₄Cu
• Molecular Weight: 403.93 g/mol (as copper complex)
• Appearance: Light blue to blue crystalline powder
• Purity (HPLC): ≥98% (minimum), with premium grades reaching ≥99%
• Solubility: Freely soluble in water (≥100 mg/mL), partially soluble in DMSO
• pH Range (1% solution): 5.5–7.0
• Storage Conditions: -20°C, desiccated, protected from light
• Shelf Life: 24 months when stored under recommended conditions

Technical Index Checklist

• Peptide Content: ≥80% (by weight, excluding counterions and water)
• Copper Content: 15.0–16.5% (by weight, verified by ICP-MS)
• Endotoxin Level: <0.5 EU/mg (for injection-grade material)
• Residual Solvents: Compliant with ICH Q3C guidelines
• Heavy Metals: <10 ppm (lead, arsenic, cadmium, mercury)

Industry data from the 2023 Peptide Raw Material Quality Report indicates that over 72% of cosmetic peptide batches fail initial quality checks due to copper content deviation or residual solvent contamination. Labs sourcing GHK Cu peptide injection for formulation work should prioritize suppliers who provide full Certificate of Analysis (CoA) with batch-specific HPLC and ICP-MS data.

Manufacturing & Quality Control

The production of GHK Cu peptide injection follows a multi-step solid-phase peptide synthesis (SPPS) process, followed by copper chelation and rigorous purification. Understanding this workflow is critical for evaluating supplier reliability and product consistency.

Production Process

• Step 1 – Solid-Phase Synthesis: The tripeptide sequence (Gly-His-Lys) is assembled on a resin support using Fmoc chemistry, with each amino acid coupled sequentially under controlled conditions.
• Step 2 – Cleavage & Deprotection: The peptide is cleaved from the resin and side-chain protecting groups are removed using TFA-based cleavage cocktails.
• Step 3 – Copper Chelation: Purified GHK peptide is reacted with copper(II) chloride or copper(II) acetate under optimized pH and temperature to form the stable GHK-Cu complex.
• Step 4 – Purification: The crude product undergoes preparative HPLC (reverse-phase C18 column) to achieve ≥98% purity.
• Step 5 – Lyophilization: The purified solution is freeze-dried to produce a stable, amorphous powder suitable for injection-grade applications.

Quality Control Protocols

• HPLC Analysis: Purity verification with UV detection at 220 nm and 280 nm
• Mass Spectrometry (MS): Molecular weight confirmation (ESI-MS or MALDI-TOF)
• Copper Content Assay: Inductively coupled plasma mass spectrometry (ICP-MS)
• Endotoxin Testing: LAL chromogenic method per USP <85>
• Sterility Testing: Membrane filtration method per USP <71>
• Moisture Content: Karl Fischer titration (<5% w/w)

Certifications & Compliance

• ISO 9001:2015 – Quality management system for manufacturing
• GMP Certification – Good Manufacturing Practice for pharmaceutical excipients
• MSDS – Material Safety Data Sheet provided with each shipment
• CoA – Certificate of Analysis with batch-specific data
• Non-Animal Origin – Statement confirming no animal-derived materials used

Commercial Application Scenarios

The GHK Cu peptide injection serves multiple B2B applications, each with distinct purity and formulation requirements. Below are the primary commercial scenarios where this raw material is utilized.

Cosmetic Formulation Development

In cosmetic R&D labs, GHK Cu peptide injection is used as an active ingredient in anti-aging serums, eye creams, and moisturizers. Formulators require material with ≥98% purity and verified copper content to ensure consistent product performance. Typical batch sizes range from 1 gram for prototype development to 100 grams for pilot-scale production. The peptide is typically incorporated at 0.1–1.0% w/w in finished formulations, requiring precise weighing and solubilization protocols.

Laboratory Research Applications

Academic and industrial research labs use GHK Cu peptide injection for cell culture studies, enzyme assays, and mechanistic investigations. Researchers demand material with documented endotoxin levels (<0.5 EU/mg) and sterility assurance for cell-based work. Common research areas include wound healing models, fibroblast proliferation assays, and collagen synthesis quantification. Bulk orders of 5–50 mg are typical for multi-experiment studies.

Bulk Wholesale Distribution

Distributors and contract manufacturers purchase GHK Cu peptide injection in kilogram quantities for resale or downstream processing. Key considerations include batch consistency, long-term stability data, and regulatory documentation. Wholesale buyers typically require material with ≥99% purity, full stability studies (12-month accelerated and 24-month real-time), and compliance with regional cosmetic ingredient regulations (e.g., EU CosIng, INCI listing).

ghk cu peptide injection VS Ordinary Low-Grade Peptides

Bulk Purchase Selection Guide

When sourcing GHK Cu peptide injection in bulk, buyers must navigate common pitfalls to ensure they receive material that meets their specifications. This guide outlines the key selection criteria and a practical checklist for procurement.

Common Pitfalls in Bulk Sourcing

• Incomplete Documentation: Suppliers who cannot provide batch-specific CoA, MSDS, and stability data often deliver inconsistent material.
• Copper Content Variability: Low-grade peptides may have copper content outside the 15.0–16.5% range, leading to formulation failures.
• Hidden Impurities: Residual solvents, TFA salts, or endotoxins can compromise research results or cosmetic product safety.
• Misleading Purity Claims: Some suppliers report purity based on UV-only detection without confirming peptide identity via MS.

Selection Standards for Bulk Buyers

• Purity Verification: Require HPLC chromatogram with UV detection at 220 nm and 280 nm, plus MS confirmation.
• Copper Assay: Insist on ICP-MS data showing copper content within 15.0–16.5%.
• Endotoxin Testing: For injection-grade or cell culture use, demand LAL test results below 0.5 EU/mg.
• Stability Studies: Request real-time and accelerated stability data covering at least 12 months.
• Regulatory Compliance: Verify GMP certification and ISO 9001:2015 accreditation.

Buyer Checklist

• ☐ Batch-specific CoA with HPLC, MS, and ICP-MS data
• ☐ MSDS and handling instructions
• ☐ Endotoxin and sterility certificates (if applicable)
• ☐ Stability study summary (12-month minimum)
• ☐ GMP and ISO certification copies
• ☐ Sample availability for in-house testing
• ☐ Lead time and minimum order quantity (MOQ) confirmation

Core Product Advantages

The GHK Cu peptide injection offered by reputable suppliers delivers several distinct advantages over generic or low-grade alternatives. These benefits directly impact research reproducibility, formulation consistency, and cost efficiency.

High Purity & Batch Consistency

With ≥98% purity verified by HPLC and MS, each batch of GHK Cu peptide injection provides consistent molecular identity and minimal impurities. This eliminates variability in experimental results and ensures that cosmetic formulations perform as intended. Batch-to-batch reproducibility is documented through comprehensive CoA data, allowing labs to maintain quality control across multiple orders.

Superior Stability & Shelf Life

Properly manufactured GHK Cu peptide injection exhibits excellent stability when stored at -20°C under desiccated, light-protected conditions. Real-time stability studies confirm a 24-month shelf life, with less than 2% degradation under recommended storage. This long-term stability reduces waste and allows bulk buyers to maintain inventory without frequent reordering.

Cost Performance & Technical Support

Bulk purchasing of GHK Cu peptide injection offers significant cost advantages compared to small-volume orders. Suppliers who maintain in-house manufacturing and quality control can provide competitive pricing without compromising purity. Additionally, dedicated technical support teams assist with formulation guidance, solubility optimization, and regulatory documentation, reducing the burden on in-house R&D staff.

Frequently Asked Questions

Q1: What is the minimum purity requirement for GHK Cu peptide injection used in cosmetic formulation?
For cosmetic formulation development, a minimum purity of 98% (HPLC) is recommended to ensure consistent active ingredient concentration and minimize the risk of impurities that could affect product stability or sensory properties. Premium-grade material at ≥99% purity is preferred for high-end formulations where batch reproducibility is critical.

Q2: How should GHK Cu peptide injection be stored to maintain stability during bulk inventory?
Bulk GHK Cu peptide injection should be stored at -20°C in airtight, light-resistant containers with desiccant. The material must remain sealed until use to prevent moisture absorption. Under these conditions, the peptide maintains ≥98% purity for 24 months. Avoid repeated freeze-thaw cycles by aliquoting into single-use vials.

Q3: What documentation should I request from a supplier before purchasing GHK Cu peptide injection in bulk?
Request a batch-specific Certificate of Analysis (CoA) that includes HPLC purity, MS confirmation, copper content (ICP-MS), endotoxin levels, moisture content, and residual solvent analysis. Additionally, obtain the Material Safety Data Sheet (MSDS), GMP certification, ISO 9001:2015 certificate, and stability study summary covering at least 12 months of real-time data.